Innovator Ibd 50 Etf Market Outlook

FFTY Etf  USD 38.07  0.33  0.87%   
Slightly above 50% of Innovator IBD's investors are presently thinking to get in. The current sentiment regarding investing in Innovator IBD 50 etf implies that some traders are interested. Innovator IBD's investing sentiment can be driven by a variety of factors including economic data, Innovator IBD's earnings reports, geopolitical events, and overall market trends.

Comfort Level 50

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Innovator IBD's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Innovator IBD 50.
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Innovator IBD 50 is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Innovator IBD 50 given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Innovator IBD 50, the advice is generated through an automated system that utilizes algorithms and statistical models.

Execute Innovator IBD Advice

The Innovator recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Innovator IBD 50. Macroaxis does not own or have any residual interests in Innovator IBD 50 or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Innovator IBD's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Innovator IBDBuy Innovator IBD
Sell

Market Performance

FairDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Not AvailableDetails

Financial Leverage

Not RatedDetails
For the selected time horizon Innovator IBD 50 has a Mean Deviation of 1.71, Semi Deviation of 2.59, Standard Deviation of 2.42, Variance of 5.84, Downside Variance of 7.86 and Semi Variance of 6.7
Innovator IBD 50 investment recommendation module can be used to check and cross-verify current trade recommendations provided by analysts evaluating the entity's potential to grow using all of fundamental, technical, data market data available at the time. Use Innovator IBD total asset and last dividend paid to ensure your buy or sell decision on Innovator IBD 50 is adequate.

Innovator IBD Trading Alerts and Improvement Suggestions

Latest headline from thelincolnianonline.com: Innovator IBD 50 ETF Trading Down 1.3 percent Time to Sell
The fund created five year return of -3.0%
Innovator IBD 50 retains 99.92% of its assets under management (AUM) in equities

Innovator IBD Returns Distribution Density

The distribution of Innovator IBD's historical returns is an attempt to chart the uncertainty of Innovator IBD's future price movements. The chart of the probability distribution of Innovator IBD daily returns describes the distribution of returns around its average expected value. We use Innovator IBD 50 price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Innovator IBD returns is essential to provide solid investment analysis for Innovator IBD.
Mean Return
0.11
Value At Risk
-4.2
Potential Upside
3.78
Standard Deviation
2.42
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Innovator IBD historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Innovator IBD Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Innovator IBD or Innovator ETFs sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Innovator IBD's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Innovator etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.04
β
Beta against Dow Jones1.51
σ
Overall volatility
2.27
Ir
Information ratio 0.03

Innovator IBD Volatility Alert

Innovator IBD 50 currently demonstrates below-average downside deviation. It has Information Ratio of 0.03 and Jensen Alpha of 0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Innovator IBD's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Innovator IBD's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Innovator IBD Fundamentals Vs Peers

Comparing Innovator IBD's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Innovator IBD's direct or indirect competition across all of the common fundamentals between Innovator IBD and the related equities. This way, we can detect undervalued stocks with similar characteristics as Innovator IBD or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Innovator IBD's fundamental indicators could also be used in its relative valuation, which is a method of valuing Innovator IBD by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Innovator IBD to competition
FundamentalsInnovator IBDPeer Average
Price To Earning24.64 X3.15 X
Price To Book3.76 X0.39 X
Price To Sales3.74 X0.33 X
Beta1.7
One Year Return14.80 %(0.97) %
Three Year Return18.90 %3.23 %
Five Year Return(3.30) %1.12 %
Ten Year Return7.50 %1.20 %
Net Asset97.73 M2.29 B
Last Dividend Paid0.05680.14
Equity Positions Weight99.92 %52.82 %

Innovator IBD Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Innovator . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Innovator IBD Buy or Sell Advice

When is the right time to buy or sell Innovator IBD 50? Buying financial instruments such as Innovator Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Innovator IBD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Funds Thematic Idea Now

Consumer Funds
Consumer Funds Theme
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Innovator IBD 50 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innovator IBD's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innovator Ibd 50 Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Innovator Ibd 50 Etf:
Check out Innovator IBD Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Innovator IBD's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.